In a nutshell This study investigated the impact monitoring an early stage prostate cancer had on quality of life or psychological state of mind. The study found that active surveillance or watchful waiting, instead of active treatment, has a minor impact on psychological and quality of life outcomes in the long-term. Some background Active...
Read More
In a nutshell This study aimed to compare the risk of cardiovascular incidents (CIs, side-effects) of surgical castration versus castration achieved by hormone therapy. The study concluded that CIs were higher for surgical treatment at 1.5 years after treatment, but similar thereafter. Some background For locally advanced or metastatic...
Read More
“For me, having lost my husband, it’s frustrating to hear publicly people saying to John McCain, ‘If anybody can beat this you can — you’re so tough.’ Not that it’s intentionally hurtful, but it does leave those of us who’ve lost a loved one thinking, ‘Was my loved one not tough enough? Did he not fight hard enough?'” ~Dannagal...
Read More
“I’m barely 27 and if it were not for immunotherapy and cancer research, I would not have seen 25.” So starts Stefanie Joho speech at a 2017 Congressional Hearing called “Progress in Immunotherapy: Delivering Hope and Clinical Benefit to Cancer Patients.” When Stefanie was 22, she was diagnosed with a very aggressive Stage II...
Read More
Video information: Have there been advances in treating advanced prostate cancer symptoms? Andrew Schorr discusses approaches for treating symptoms and complications in men with advanced prostate cancer with Dr. Philip Kantoff of Memorial Sloan Kettering Cancer Center. Watch as Dr. Kantoff explains how radiation therapy and various...
Read More
September is Prostate Cancer Awareness Month. To increase awareness, Medivizor is sharing a theory from researchers at Johns Hopkins University School of Medicine that attempts to explain what may be causing men in Europe and the US to be so vulnerable to prostate cancer. What does the prostate gland do? The prostate gland is part of the male...
Read More
From September 8 through 12th, over 24,000 oncologists and oncology researchers attended the European Society of Medical Oncology Meeting (ESMO), the equivalent of the American Society of Clinical Oncology Meeting (ASCO) held in the US. This year’s event focused on connecting researchers to practitioners in a meaningful way. Here are some research...
Read MoreIn a nutshell The authors aimed to determine long-term quality of life (QoL) in men with prostate cancer who received cesium-131 brachytherapy. The authors concluded that there are minimal long-term changes in urinary or bowel patient-reported QoL following Cs brachytherapy. Some background Radiation therapy is a form of treatment used in...
Read More
In a nutshell The authors aimed to determine patients who would benefit from early salvage radiation therapy (SRT) after prostate surgery. The authors concluded that early SRT is only beneficial for selected patients who experience cancer recurrence after prostate surgery. Some background Prostate surgery is a common prostate cancer...
Read MoreIn a nutshell The authors aimed to determine the effects of yoga on fatigue, erectile dysfunction, urinary problems and quality of life (QoL) in men undergoing radiation therapy for prostate cancer. The authors concluded that yoga twice-weekly during external beam radiation therapy (EBRT) significantly reduced pre-existing and radiation-related...
Read MoreIn a nutshell The authors aimed to determine the benefit of exercise before and after prostate cancer diagnosis and its effect on prostate cancer-specific mortality in men. The authors concluded that men with non-metastatic (cancer that has not spread into surrounding organs) prostate cancer who exercised more after diagnosis had a lower risk of...
Read MoreIn a nutshell The authors aimed to determine the efficacy and safety of hypofractionated radiation therapy compared to conventional radiation therapy in men with localised prostate cancer. The authors concluded that hypofractionated therapy was beneficial to men with localised prostate cancer, without enhancing side effects, in comparison to...
Read More
